Diphenhydramine Dosing in Neonates
The American Academy of Pediatrics does not provide specific dosing recommendations for diphenhydramine in neonates, indicating caution should be exercised when considering its use in this population. 1
Dosing Considerations
- Pediatric guidelines mention diphenhydramine for acute hypersensitivity reactions and dystonic reactions at 1-2 mg/kg IV/IM (maximum 50 mg), but these recommendations are not specific to neonates 2, 1
- Neonates are particularly vulnerable to adverse effects of antihistamines due to their immature metabolic pathways and blood-brain barrier 1, 3
- Rapid IV administration of diphenhydramine should be avoided in neonates as it may precipitate seizures 1
Clinical Approach to Allergic Reactions in Neonates
- For allergic reactions in neonates requiring intervention:
Safety Concerns
- Diphenhydramine can cause significant adverse effects in neonates, including:
Emergency Situations
- If diphenhydramine must be used in emergency situations for severe allergic reactions when no alternatives exist:
Alternative Approaches
- Second-generation antihistamines have fewer adverse effects because they are more selective for peripheral H1 receptors, but most lack specific dosing guidelines for neonates 3
- Many antihistamines are prescribed off-label in children younger than 2 years of age, where safety data are most lacking 3
Toxicity Considerations
- For suspected diphenhydramine overdose in children under 6 years, a threshold of 7.5 mg/kg warrants emergency department referral 6
- Symptoms of toxicity include changes in behavior beyond mild drowsiness, agitation, hallucinations, abnormal muscle movements, loss of consciousness, seizures, or respiratory depression 6